{"transactions":[{"id":726390,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-25T22:57:29.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option will vest and become exercisable in full on June 23, 2027 subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.15,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-283202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526283202/ownership.xml","form_type":"4"}},{"id":726389,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T22:57:29.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on June 23, 2027, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001193125-26-283202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000119312526283202/ownership.xml","form_type":"4"}},{"id":770392,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:14:08.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":22000,"derivative":{"exercise_price":4.52,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001566617-26-000002","document":"wk-form4_1779308045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000156661726000002/wk-form4_1779308045.xml","form_type":"4"}},{"id":770391,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:14:08.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001566617-26-000002","document":"wk-form4_1779308045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000156661726000002/wk-form4_1779308045.xml","form_type":"4"}},{"id":770390,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-20T20:14:08.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001566617-26-000002","document":"wk-form4_1779308045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000156661726000002/wk-form4_1779308045.xml","form_type":"4"}},{"id":770389,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:14:08.000Z","date":"2026-05-18","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":14750,"source":{"system":"sec-edgar","filing":"0001566617-26-000002","document":"wk-form4_1779308045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000156661726000002/wk-form4_1779308045.xml","form_type":"4"}},{"id":979209,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T09:01:56.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2033-12-13","underlying":"Ordinary Shares","underlying_shares":15021},"source":{"system":"sec-edgar","filing":"0001193125-25-308773","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308773/ownership.xml","form_type":"4"}},{"id":979208,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T09:01:56.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8462,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":3.35,"expiration_date":"2034-05-29","underlying":"Ordinary Shares","underlying_shares":8462},"source":{"system":"sec-edgar","filing":"0001193125-25-308773","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308773/ownership.xml","form_type":"4"}},{"id":979207,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T09:01:56.000Z","date":"2025-12-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Transaction Agreement (the \"Agreement\"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. (\"Sub\"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, pursuant to which Sub acquired all the issued and to be issued share capital of the Issuer (the \"Acquisition\") for a cash purchase price of $2.035 per share (the \"Scheme Consideration\"). The Acquisition was completed as of December 5, 2025 (the \"Effective Time\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options."}],"balance_after":0,"derivative":{"exercise_price":2.56,"expiration_date":"2035-06-10","underlying":"Ordinary Shares","underlying_shares":8637},"source":{"system":"sec-edgar","filing":"0001193125-25-308773","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000119312525308773/ownership.xml","form_type":"4"}},{"id":1109818,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T00:29:35.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on June 12, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000950170-25-087017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017025087017/ownership.xml","form_type":"4"}},{"id":1112083,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T08:00:07.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":8637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2025. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer."}],"balance_after":8637,"derivative":{"exercise_price":2.56,"expiration_date":"2035-06-10","underlying":"Ordinary Shares","underlying_shares":8637},"source":{"system":"sec-edgar","filing":"0000950170-25-085819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017025085819/ownership.xml","form_type":"4"}},{"id":1137749,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T20:03:01.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":22000,"derivative":{"exercise_price":1.49,"expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001125345-25-000083","document":"wk-form4_1747944173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000083/wk-form4_1747944173.xml","form_type":"4"}},{"id":1137748,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T20:03:01.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":3750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001125345-25-000083","document":"wk-form4_1747944173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000083/wk-form4_1747944173.xml","form_type":"4"}},{"id":1137747,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T20:03:01.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001125345-25-000083","document":"wk-form4_1747944173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000083/wk-form4_1747944173.xml","form_type":"4"}},{"id":1137746,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:03:01.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":true,"shares":6500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001125345-25-000083","document":"wk-form4_1747944173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534525000083/wk-form4_1747944173.xml","form_type":"4"}},{"id":1490398,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-05T16:10:58.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":8462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This amendment to Form 4 is being filed solely to correct the price of the derivative security, which was previously reported as being $3.35 due to a scrivener's error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer."}],"balance_after":8462,"derivative":{"exercise_price":3.35,"expiration_date":"2034-05-29","underlying":"Ordinary Shares","underlying_shares":8462},"source":{"system":"sec-edgar","filing":"0000950170-24-069314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024069314/ownership.xml","form_type":"4/A","original_submission_date":"2024-06-03"}},{"id":1495390,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T10:14:16.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":8462,"price":3.35,"value":28347.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024. This option will vest in full upon the earlier of (i) the first anniversary of the date of the grant or (ii) the date of the next Annual Meeting, subject to the reporting person's continued service with the Issuer."}],"balance_after":8462,"derivative":{"exercise_price":3.35,"expiration_date":"2034-05-29","underlying":"Ordinary Shares","underlying_shares":8462},"source":{"system":"sec-edgar","filing":"0000950170-24-067707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024067707/ownership.xml","form_type":"4"}},{"id":1497883,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:27:14.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on May 29, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0000950170-24-066652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017024066652/ownership.xml","form_type":"4"}},{"id":1504077,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T21:16:03.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":16500,"derivative":{"exercise_price":4.26,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001125345-24-000126","document":"wk-form4_1716498951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000126/wk-form4_1716498951.xml","form_type":"4"}},{"id":1504076,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-23T21:16:03.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":6500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001125345-24-000126","document":"wk-form4_1716498951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000126/wk-form4_1716498951.xml","form_type":"4"}},{"id":1505901,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-22T20:34:11.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001125345-24-000107","document":"wk-form4_1716410040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000107/wk-form4_1716410040.xml","form_type":"4"}},{"id":1505900,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T20:34:11.000Z","date":"2024-05-20","kind":"exercise","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001125345-24-000107","document":"wk-form4_1716410040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534524000107/wk-form4_1716410040.xml","form_type":"4"}},{"id":1531808,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-01T20:25:19.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 1, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.62,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-011861","document":"form4-05012024_080513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000141588924011861/form4-05012024_080513.xml","form_type":"4"}},{"id":1707634,"issuer":{"id":72153,"kind":"organization","name":"Mural Oncology plc","symbol":"MURA"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-18T16:30:31.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":15021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 14, 2023. This option shall vest over three years in twelve equal quarterly installments on each quarterly anniversary of October 31, 2023, subject to the reporting person's continued service with the Issuer."}],"balance_after":15021,"derivative":{"exercise_price":3.61,"expiration_date":"2033-12-13","underlying":"Ordinary Shares","underlying_shares":15021},"source":{"system":"sec-edgar","filing":"0000950170-23-071110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017023071110/ownership.xml","form_type":"4"}},{"id":1762598,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T21:19:44.000Z","date":"2023-10-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on October 5, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0000950170-23-052693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000095017023052693/ownership.xml","form_type":"4"}},{"id":1870561,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:57:09.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier"}],"balance_after":4500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001125345-23-000098","document":"wk-form4_1685739418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000098/wk-form4_1685739418.xml","form_type":"4"}},{"id":1870560,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:57:09.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":19000,"derivative":{"exercise_price":4.67,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001125345-23-000098","document":"wk-form4_1685739418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534523000098/wk-form4_1685739418.xml","form_type":"4"}},{"id":1882301,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T20:18:57.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 19, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.98,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-031443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919123031443/doc4.xml","form_type":"4"}},{"id":2155777,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-19T21:45:11.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on September 15, 2023, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000899243-22-031505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924322031505/doc4.xml","form_type":"4"}},{"id":2260427,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-24T01:07:02.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":18000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001125345-22-000065","document":"wf-form4_165335440496083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534522000065/wf-form4_165335440496083.xml","form_type":"4"}},{"id":2261556,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T20:10:53.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 18, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-22-030982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919122030982/doc4.xml","form_type":"4"}},{"id":2597973,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-18T20:48:03.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest and become exercisable in full on August 17, 2022 subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":13.69,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-21-033460","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924321033460/doc4.xml","form_type":"4"}},{"id":2692872,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T00:55:58.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":10500,"derivative":{"exercise_price":2.55,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-21-036382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919121036382/doc4.xml","form_type":"4"}},{"id":2692871,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T00:55:58.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying these restricted stock units vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001209191-21-036382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919121036382/doc4.xml","form_type":"4"}},{"id":2710613,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T01:28:46.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":28.88,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001125345-21-000074","document":"wf-form4_162130130131615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534521000074/wf-form4_162130130131615.xml","form_type":"4"}},{"id":2999341,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-27T21:34:56.000Z","date":"2020-10-27","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest and become exercisable in full on October 27, 2021 subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":7500,"derivative":{"exercise_price":13.52,"expiration_date":"2030-10-27","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-20-029333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924320029333/doc4.xml","form_type":"4"}},{"id":3102013,"issuer":{"id":7014,"kind":"organization","name":"Spero Therapeutics, Inc."},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-23T21:33:01.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in thirty-six equal monthly installments at the end of each successive month following June 23, 2020, subject to the Reporting Person's continued service as a director through the applicable vesting dates."}],"balance_after":15000,"derivative":{"exercise_price":13.94,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-017496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701108/000089924320017496/doc4.xml","form_type":"4"}},{"id":3133339,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-27T20:29:41.000Z","date":"2020-05-22","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":3,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-20-032304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919120032304/doc4.xml","form_type":"4"}},{"id":3147651,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-15T20:37:28.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":24.97,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001125345-20-000091","document":"wf-form4_158957503190453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534520000091/wf-form4_158957503190453.xml","form_type":"4"}},{"id":3516599,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-21T20:04:25.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":21000,"derivative":{"exercise_price":12.39,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-19-031714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919119031714/doc4.xml","form_type":"4"}},{"id":3518820,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-20T21:47:59.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":18,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-19-000073","document":"wf-form4_155838886506188.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534519000073/wf-form4_155838886506188.xml","form_type":"4"}},{"id":3750131,"issuer":{"id":5255,"kind":"organization","name":"CRESCENT BIOPHARMA, INC.","symbol":"CBIO"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-29T00:01:15.000Z","date":"2018-11-27","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was made pursuant to the issuer's non-employee director compensation policy. The shares underlying this option vest in three\nequal installments on November 27, 2019, 2020 and 2021, subject to the reporting person's continuous service with the issuer at each vesting date."}],"balance_after":22000,"derivative":{"exercise_price":11.52,"expiration_date":"2028-11-26","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-18-060160","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253689/000120919118060160/doc4.xml","form_type":"4"}},{"id":3924227,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-21T20:53:17.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":21.34,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-18-000069","document":"wf-form4_152693598301732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534518000069/wf-form4_152693598301732.xml","form_type":"4"}},{"id":4310246,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-22T23:02:59.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":19.57,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001125345-17-000080","document":"wf-form4_149549416283411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000080/wf-form4_149549416283411.xml","form_type":"4"}},{"id":4481994,"issuer":{"id":6104,"kind":"organization","name":"MACROGENICS INC","symbol":"MGNX"},"owners":[{"id":35381,"kind":"person","name":"Jackson Scott Thomas","position":1,"cik":"0001566617","reported_name":"Jackson Scott Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-25T22:56:21.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest 1/12th of the shares monthly, beginning on the first monthly anniversary of the grant date and will become fully exercisable 1 year from the date of grant (1/24/18)."}],"balance_after":20000,"derivative":{"exercise_price":18.52,"expiration_date":"2027-01-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001125345-17-000012","document":"wf-form4_148538496854009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1125345/000112534517000012/wf-form4_148538496854009.xml","form_type":"4"}}]}